Welcome to our dedicated page for Mustgrow Biologics news (Ticker: MGROF), a resource for investors and traders seeking the latest updates and insights on Mustgrow Biologics stock.
MustGrow Biologics Corp. reports developments in biological and regenerative agriculture, including mustard-derived biofertility, biostimulant and biocontrol products. News commonly covers commercialization of TerraSante in U.S. agricultural markets, field work for TerraMG in soil-borne disease suppression, and crop nutrition sales through the NexusBioAg Canadian distribution platform.
Company updates also address annual and quarterly financial results, capital raises, inventory and working-capital funding, organic product registrations, patent portfolio activity, and collaborations with agriculture companies outside North America.
Summary not available.
Summary not available.
Summary not available.
OTC Markets Group Inc. announced that MustGrow Biologics Corp. has qualified to trade on the OTCQX Best Market, upgrading from the OTCQB Venture Market. Trading under the symbol MGROF, MustGrow focuses on natural science-based solutions for high-value crops. This upgrade signifies MustGrow's adherence to high financial standards and corporate governance, enhancing visibility among U.S. investors. MustGrow has a product approved by the U.S. EPA for pest and disease protection in crops, with over 110 tests validating its safety and effectiveness.
MustGrow Biologics Corp (OTCQB:MGROF), an agriculture biotech firm, will participate in the virtual Fall Investor Summit from November 16-18, 2020. This event features 75 companies and connects over 300 investors. MustGrow focuses on natural, science-based biological solutions for crops, including a patented EPA-approved product derived from mustard seeds. The company has conducted over 110 independent tests to confirm its products' safety and efficacy. With approximately 37 million shares outstanding, MustGrow aims to elevate its profile among investors.